Drug Patent Expirations in April 2010

Drug Patent Expirations in April 2010

*Drugs may be covered by multiple patents

TradenameApplicantGeneric NamePatent Number Patent Expiration
HYZAARMerckhydrochlorothiazide; losartan potassium5,153,197*PEDApr 6, 2010
IPLEXInsmedmecasermin rinfabate recombinant5,200,509Apr 6, 2010
COZAARMercklosartan potassium5,153,197*PEDApr 6, 2010
DUODOTEMeridian Medclatropine; pralidoxime chloride5,092,843Apr 12, 2010
EMBEDAAlpharma Kingmorphine sulfate; naltrexone hydrochloride5,202,128Apr 13, 2010
KADIANActavis Elizabethmorphine sulfate5,202,128Apr 13, 2010
MUSEVivusalprostadil5,773,020Apr 25, 2010
FLOMAXBoehringer Ingelheimtamsulosin hydrochloride4,703,063*PEDApr 27, 2010

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.Courtesy of DrugPatentWatch.com

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog